Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Clinical Study of Macitentan in Patients With Pulmonary Arterial Hypertension to Psychometrically Validate the PAH-SYMPACT Instrument

ClinicalTrials.gov ID: NCT01841762

Public ClinicalTrials.gov record NCT01841762. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 22, 2026, 8:44 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multi-center, Open-label, Single-arm, Phase 3b Study of Macitentan in Patients With Pulmonary Arterial Hypertension to Psychometrically Validate the PAH-SYMPACT Instrument

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

SYMPHONY is prospective, multi-center, open-label, single-arm, Phase 3b psychometric validation study of the PAH-SYMPACT, a new quality of life questionnaire for patients with pulmonary arterial hypertension. Patients will be in the study for 5 1/2 months, 4 months of which they will receive macitentan, 10 mg, once daily. The primary objectives are to demonstrate the final content validity of the PAH SYMPACT instrument, to demonstrate the psychometric characteristics of reliability and construct validity of the PAH-SYMPACT instrument, and to demonstrate the ability of the PAH SYMPACT instrument to detect change. The secondary objective is to assess the safety of macitentan in patients with pulmonary arterial hypertension. The exploratory objective is to explore the effects of macitentan on PAH symptoms and their impact (as measured by the PAH-SYMPACT) in patients with pulmonary arterial hypertension.

Study identification

NCT ID
NCT01841762
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Actelion
Industry
Enrollment
284 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 1, 2013 (Actual)
Primary completion
Nov 1, 2015 (Actual)
Completion
Nov 1, 2015 (Actual)
Last update posted
Feb 26, 2019

2013 – 2015

United States locations

U.S. sites
81
U.S. states
29
U.S. cities
60
Facility City State ZIP Site status
Cardiovascular Associates of the Southeast, LLC Birmingham Alabama 35243 —
University of Alabama at Birmingham Birmingham Alabama 35294 —
Pulmonary Associates, PA Phoenix Arizona 85006-2611 —
Mayo Clinic Arizona Phoenix Arizona 85054-4502 —
Cedars-Sinai Medical Center Beverly Hills California 90211 —
UCSF Fresno Fresno California 93701 —
UCSD Medical Center, Pulmonary Department La Jolla California 92093 —
VAGLAHS, VA Greater LA Healthcare System Los Angeles California 90073 —
University of California Los Angeles Los Angeles California 90095 —
University of California San Francisco Medical Center San Francisco California 94143 —
Stanford University Stanford California 94305-2200 —
Los Angeles Biomedical Research Institute Torrance California 90502 —
University of Colorado Aurora Colorado 80045 —
MedStar Georgetown University Hospital Washington D.C. District of Columbia 20007 —
Medstar Washington Hospital Center Washington D.C. District of Columbia 20010 —
Bay Area Cardiology Associates, P.A. Brandon Florida 33511 —
University of Florida Academic Health Center Gainesville Florida 32610 —
University of Florida College of Medicine, Jacksonville Jacksonville Florida 32209 —
Mayo Clinic Jacksonville Florida 32224-1865 —
Cleveland Clinic Florida Weston Florida 33331-3609 —
Georgia Regents University Augusta Georgia 30912 —
Georgia Clinical Research Austell Georgia 30106 —
Northwestern University Chicago Illinois 60611 —
University of Chicago Medical Chicago Illinois 60637 —
Advocate Health and Hospitals Corporation Oakbrook Terrace Illinois 60181 —
Chest Infectious Diseases and Critical Care Associates, PC Des Moines Iowa 50325-7046 —
University of Iowa Hospitals & Clinics Iowa City Iowa 52242 —
Iowa City Heart Center Iowa City Iowa 52245 —
University of Kansas Medical Center Kansas City Kansas 66160-0001 —
Veritas Clinical Specialties Topeka Kansas 66606 —
Kentuckiana Pulmonary Associates Louisville Kentucky 40202 —
University of Louisville Louisville Kentucky 40202 —
University of Maryland Medical Center Baltimore Maryland 21201 —
Johns Hopkins University Baltimore Maryland 21205 —
Tufts Medical Center Boston Massachusetts 02111 —
Boston University Medical Center Boston Massachusetts 02118 —
University of Michigan Ann Arbor Michigan 48109-5644 —
Beaumont Hospital Troy Michigan 48085 —
Mayo Clinic Rochester Minnesota 55905 —
Midwest Pulmonary Consultants Kansas City Missouri 64111 —
Ferrell-Duncan Clinic Springfield Missouri 65807 —
Washington University School of Medicine St Louis Missouri 63110 —
Mercy Clinic Pulmonology St Louis Missouri 63141 —
Clayton Sleep Institute St Louis Missouri 63143 —
Nebraska Pulmonary Specialties Lincoln Nebraska 68506 —
University of Nebraska Medical Center Omaha Nebraska 68198 —
Pulmonary and Critical Care Associates Union New Jersey 07083 —
Buffalo General Medical Center Buffalo New York 14203 —
Winthrop University Hospital Mineola New York 11501 —
North Shore-LIJ/Advance Lung Disease Clinic New Hyde Park New York 11040 —
Beth Israel Medical Center New York New York 10003 —
Columbia University Medical Center New York New York 10032 —
Montefiore Medical Center, Weiler Division The Bronx New York 10461 —
University of North Carolina at Chapel Hill Chapel Hill North Carolina 27599 —
Novant Health Pulmonary and Critical Care Matthews North Carolina 28105 —
The Christ Hospital Cincinnati Ohio 45219 —
UC Health/University of Cincinnati Cincinnati Ohio 45267 —
Cleveland Clinic Cleveland Ohio 45219 —
Davis Heart & Lung Research Institute Columbus Ohio 43210-1252 —
The Ohio State University Columbus Ohio 43221 —
University of Oklahoma Health Sciences Center Oklahoma City Oklahoma 73104 —
The Oregon Clinic Portland Oregon 97220 —
CDA for Oregon Pulmonary Associate Portland Oregon 97225 —
Oregon Health and Science University Portland Oregon 97239 —
Thomas Jefferson University, Division on Pulmonary and Critical Care Philadelphia Pennsylvania 19107-5109 —
Temple Lung Center Philadelphia Pennsylvania 19140 —
UPMC Pittsburgh Pennsylvania 15123 —
Allegheny General Hospital Pittsburgh Pennsylvania 15212-4756 —
Berks Schuylkill Respiratory Specialists, Ltd. Wyomissing Pennsylvania 19610 —
Wellspan Lung, Sleep and Critical Care York Pennsylvania 17402-8200 —
Sioux Falls Cardiovascular, PC Sioux Falls South Dakota 57108 —
Baylor Research Institute (BRI) Dallas Texas 75204 —
UT Southwestern Medical Center Dallas Texas 75390-8550 —
Baylor College of Medicine Houston Texas 77030-2348 —
The University of Texas Health Science Center at Houston Houston Texas 77030 —
Scott & White Memorial Hospital Temple Texas 76508 —
Inova Heart and Vascular Institue / Inova Fairfax Hospital Falls Church Virginia 22042-3307 —
Sentara Norfolk General Hospital Norfolk Virginia 23507 —
Pulmonary & Sleep Research Spokane Washington 99204 —
University of Wisconsin School of Medicine and Public Health Madison Wisconsin 53792 —
Aurora Cardiovascular Services Milwaukee Wisconsin 53215 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01841762, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 26, 2019 · Synced Oct 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01841762 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →